Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century (2024)

個数:

Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century (2024)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 376 p.
  • 言語 ENG
  • 商品コード 9783031573682

Full Description

In the face of recent viral outbreaks and a global viral pandemic, the necessity for innovation and continued rapid advancement in viral diagnosis and treatment methods has become even more apparent. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century explores the latest advances in virology and trends in clinical practice, focused on foundational principles and advancements expected to significantly impact this field. Chapters address SARS-CoV-2, Ebola, Zika, Mpox, and Hepatitis C, among other key viral threats, before presenting a detailed analysis of antiviral agents broadly and concerning specific vulnerable populations such as stem cell and solid organ transplant recipients. It is designed as a helpful resource for medical students, scientists, and professionals, bridging current practice and future applications and inspiring further innovations and improvements in global health.

Contents

.- 1. The genome sequence analysis of SARS- CoV-2 variants of concern.- 2. Influenza: Clinical challenges in the 21st century.- 3. Ebola: Virology, clinical considerations, and outbreak response and prevention.- 3. A clinical approach to novel diagnostics and therapeutics: The challenge of Zika.- .5 Oncogenic human papillomavirus.- 6. Hepatitis C virus infection in people who inject drugs.- 7. Hepatitis C: Updates in epidemiology and treatment with direct-acting antivirals.- 8. NeuroAIDS, comorbid mood disorders and neuropsychiatric effects of antiretroviral therapy.- 9. Marijuana and HIV.- 10. Mpox: An emerging global orthopoxvirus outbreak.- 11. Community-acquired respiratory infections in HCT and immunosuppressed patients.- 12. COVID-19 in cancer and hematopoietic stem cell transplant recipients.- 13. Epstein-Barr virus: Acute infection, oncogenesis, prevention and pitfalls.- 14. Human herpesvirus 6A, 6B, 7 and 8 in hematopoietic stem cell transplant: A clinical review.- 15. Cytomegalovirus infections in hematopoietic cell transplant and solid organ transplant recipients.- 16. Herpes simplex virus and varicella zoster virus in hematopoietic stem cell transplant recipients.- 17. The virology of hemophagocytic lymphohistiocytosis.- 18. Antiviral agents: Cidofovir and Brincidofovir.- 19. Antiviral agents: Ganciclovir and valganciclovir.- 20. Antiviral agents: Letermovir.- 21. Antiviral agents: Maribavir.- 22. Antiviral agents in the hematopoietic stem cell transplant population: Acyclovir, valacyclovir, penciclovir and famciclovir.- 23. Antiviral agents in the hematopoietic stem cell transplant population: Foscarnet.- 24. Radioimmunotherapy: An overview.

最近チェックした商品